127 related articles for article (PubMed ID: 25815466)
1. The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining.
Rahman SA; West SK; Mkocha H; Munoz B; Porco TC; Keenan JD; Lietman TM
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003682. PubMed ID: 25815466
[TBL] [Abstract][Full Text] [Related]
2. The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing.
Lietman TM; Gebre T; Abdou A; Alemayehu W; Emerson P; Blumberg S; Keenan JD; Porco TC
Epidemics; 2015 Jun; 11():85-91. PubMed ID: 25979286
[TBL] [Abstract][Full Text] [Related]
3. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
[TBL] [Abstract][Full Text] [Related]
4. When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
Ray KJ; Lietman TM; Porco TC; Keenan JD; Bailey RL; Solomon AW; Burton MJ; Harding-Esch E; Holland MJ; Mabey D
PLoS Negl Trop Dis; 2009 Jun; 3(6):e458. PubMed ID: 19529761
[TBL] [Abstract][Full Text] [Related]
5. A rationale for continuing mass antibiotic distributions for trachoma.
Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
[TBL] [Abstract][Full Text] [Related]
6. Mathematical Modelling of Trachoma Transmission, Control and Elimination.
Pinsent A; Blake IM; Basáñez MG; Gambhir M
Adv Parasitol; 2016; 94():1-48. PubMed ID: 27756453
[TBL] [Abstract][Full Text] [Related]
7. Serology for trachoma surveillance after cessation of mass drug administration.
Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
[TBL] [Abstract][Full Text] [Related]
8. Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal.
Harding-Esch EM; Kadimpeul J; Sarr B; Sane A; Badji S; Laye M; Sillah A; Burr SE; MacLeod D; Last AR; Holland MJ; Mabey DC; Bailey RL
BMC Public Health; 2017 Jul; 18(1):62. PubMed ID: 28747198
[TBL] [Abstract][Full Text] [Related]
9. Detection of Chlamydia trachomatis ocular infection in trachoma-endemic communities by rRNA amplification.
Yang JL; Hong KC; Schachter J; Moncada J; Lekew T; House JI; Zhou Z; Neuwelt MD; Rutar T; Halfpenny C; Shah N; Whitcher JP; Lietman TM
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):90-4. PubMed ID: 18689701
[TBL] [Abstract][Full Text] [Related]
10. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
[TBL] [Abstract][Full Text] [Related]
11. Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.
West SK; Munoz B; Weaver J; Mrango Z; Dize L; Gaydos C; Quinn TC; Martin DL
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004352. PubMed ID: 26771906
[TBL] [Abstract][Full Text] [Related]
12. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
[TBL] [Abstract][Full Text] [Related]
13. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
[TBL] [Abstract][Full Text] [Related]
14. The epidemiological dynamics of infectious trachoma may facilitate elimination.
Lietman TM; Gebre T; Ayele B; Ray KJ; Maher MC; See CW; Emerson PM; Porco TC;
Epidemics; 2011 Jun; 3(2):119-24. PubMed ID: 21624783
[TBL] [Abstract][Full Text] [Related]
15. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
16. Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis.
Zambrano AI; Muñoz BE; Mkocha H; Dize L; Gaydos CA; Quinn T; West SK
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):997-1000. PubMed ID: 28535271
[TBL] [Abstract][Full Text] [Related]
17. Population-Based Study of Trachoma in Guatemala.
Silva JC; Diaz MA; Maul E; Munoz BE; West SK
Ophthalmic Epidemiol; 2015; 22(3):231-6. PubMed ID: 26158582
[TBL] [Abstract][Full Text] [Related]
18. Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics.
Ervin AM; Mkocha H; Munoz B; Dreger K; Dize L; Gaydos C; Quinn TC; West SK
Ophthalmic Epidemiol; 2016 Dec; 23(6):347-353. PubMed ID: 27820670
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and assessment of trachoma.
Solomon AW; Peeling RW; Foster A; Mabey DC
Clin Microbiol Rev; 2004 Oct; 17(4):982-1011, table of contents. PubMed ID: 15489358
[TBL] [Abstract][Full Text] [Related]
20. Strategies for control of trachoma: observational study with quantitative PCR.
Solomon AW; Holland MJ; Burton MJ; West SK; Alexander ND; Aguirre A; Massae PA; Mkocha H; Muñoz B; Johnson GJ; Peeling RW; Bailey RL; Foster A; Mabey DC
Lancet; 2003 Jul; 362(9379):198-204. PubMed ID: 12885481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
